Unique Ingredient Identifier XM0M87F357 is listed as a ingredient substance
| RN | 1317-61-9 |
| EC | 215-277-5 |
| NCIT | C38138 |
| RXCUI | 1310708 |
| MF | 3Fe.4O |
| INCHI KEY | WTFXARWRTYJXII-UHFFFAOYSA-N |
| SMILES | [O--].[O--].[O--].[O--].[Fe++].[Fe+3].[Fe+3] |
UNII XM0M87F357 FERROSOFERRIC OXIDE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 0.96 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 0.17 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN | 0.93 MG |
| ORAL | CAPSULE, COATED | 0.0576 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 0.015 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.89 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 0.887 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 0.86 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | NA |
| ORAL | CAPSULE, FILM COATED, EXTENDED RELEASE | 0.0093 MG |
| ORAL | CAPSULE, HARD GELATIN | 0.02 MG |
| ORAL | CAPSULE, SOFT GELATIN | 0.3 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 1.49 MG |
| ORAL | POWDER, FOR SUSPENSION | NA |
| ORAL | TABLET | 0.3 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 0.024 MG |
| ORAL | TABLET, COATED | NA |
| ORAL | TABLET, CONTROLLED RELEASE | 0.32 MG |
| ORAL | TABLET, DELAYED ACTION | 0.12 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | TABLET, EXTENDED RELEASE | 4 MG |
| ORAL | TABLET, FILM COATED | 0.2 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 0.11 MG |
| ORAL | TABLET, SUSTAINED ACTION | 0.62 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 1.23 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.002 MG |